Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
02/2012
02/09/2012US20120034517 Secondary battery using an electrolyte solution
02/09/2012US20120034270 S1P Receptors Modulators
02/09/2012CA2807292A1 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat proteins
02/09/2012CA2806664A1 Arylsulfonamide derivatives, compositions, and methods of use
02/09/2012CA2805206A1 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf
02/08/2012EP2415766A1 Method for manufacturing benzodiazepine derivative
02/08/2012EP2415760A2 CCR-9 antagonists
02/08/2012EP2415758A1 Fluorine-containing n-alkyl sulfonyl imide compound, manufacturing method therefor, and method of manufacturing an ionic compound
02/08/2012EP2415709A1 Method for producing bis(fluorosulfonyl)imide salt, method for producing fluorosulfate, and method for producing bis(fluorosulfonyl)imide onium salt
02/08/2012CN102344379A Ionic liquid containing nitrogen-containing cation
02/08/2012CN101094829B 新的氨茴酸衍生物或其盐 The new anthranilic acid derivative or a salt thereof
02/08/2012CN101092402B 磺酰脲类化合物及其医药用途 Sulfonylurea compounds and their pharmaceutical use
02/02/2012WO2012014127A1 5-lipoxygenase inhibitors
02/02/2012WO2012013727A1 Cyclopropylamine derivatives useful as lsd1 inhibitors
02/01/2012EP2132174B1 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors
02/01/2012CN102336679A 7-substituted tetracycline compounds
01/2012
01/31/2012US8106213 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
01/31/2012CA2391952C Inhibitors of histone deacetylase
01/29/2012CA2746890A1 Novel compounds for medical use as peptidase effectors
01/26/2012WO2012010752A1 Preparation of metal salts of triflic acid and of triflimidic acid under ultrasound treatment
01/26/2012US20120022269 Fluorine-containing n-alkylsulfonylimide compound, manufacturing method therefor, and method of manufacturing an ionic compound
01/26/2012US20120022154 N-hydroxy c29-amide derivatives of oleandrane
01/26/2012US20120021933 Small molecule printing
01/25/2012EP2408557A2 Process for hydrogenating ketones in the presence of ru (ii) catalysts
01/25/2012CN102333763A Method for manufacturing benzodiazepine derivative
01/25/2012CN102333759A Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
01/25/2012CN102332609A Power storage device, lithium-ion secondary battery, electric double layer capacitor and lithium-ion capacitor
01/25/2012CN102329255A Process for synthesizing fomesafen through directional nitration
01/25/2012CN102329254A Method for preparing N-[4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]methylsulfonyl benzylamine hydrochloride
01/25/2012CN101146768B Method for producing sulfamate-carboxylate derivative
01/24/2012US8101800 5,6-dihydro-1H-pyridin-2-one compounds
01/24/2012US8101640 Antibacterial agents
01/24/2012CA2656216C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
01/24/2012CA2511582C 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
01/19/2012WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof
01/19/2012WO2012007883A1 Sulfonamide derivatives as nav1.7 inhibitors for the treatment of pain
01/19/2012WO2012007868A2 Chemical compounds
01/19/2012US20120016125 Method for preparing dipeptidyl peptidase-iv inhibitor and intermediate
01/19/2012US20120015993 Novel Pharmaceutical Forms, and Methods of Making and Using the Same
01/19/2012US20120015992 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins
01/19/2012CA2804877A1 Sulfonamide derivatives as nav1.7 inhibitors for the treatment of pain
01/19/2012CA2804716A1 Chemical compounds
01/19/2012CA2804351A1 Chemical compounds
01/18/2012CN102320997A Para-acetylsulfanilamide synthesis method combined with waste water treatment
01/18/2012CN101087754B Novel cyclohexane derivatives
01/12/2012US20120010401 Method for manufacturing 1,5-benzodiazepine derivative
01/12/2012US20120010283 Modulation of anxiety through blockade of anandamide hydrolysis
01/12/2012US20120010207 Chemical Compounds
01/12/2012US20120009683 Fluorescent Metal Ion Indicators with Large Stokes Shifts
01/12/2012CA2794129A1 Cosmetic use of n-substituted sulfonyloxybenzylamines and related compounds
01/11/2012EP2404890A1 Hydroxyl compounds and compositions for cholesterol management and related uses
01/11/2012EP1809597B1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
01/11/2012CN101830854B Substituted phenylhydrazones compounds, preparation method and application thereof
01/11/2012CN101412687B Preparation of optically-active pure ibutilide fumarate
01/10/2012US8093424 Tetralin and indane derivatives and uses thereof
01/10/2012US8093386 Thioaryl substituted inhibitors of zinc proteases and their use
01/10/2012US8093241 Acid amide derivatives, process for their production and pesticides containing them
01/05/2012US20120004225 Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use
01/05/2012US20120004183 Unnatural reactive amino acid genetic code additions
01/05/2012US20120002349 Power storage device, lithium-ion secondary battery, electric double layer capacitor and lithium-ion capacitor
01/05/2012US20120000790 Electrorecovery of metals
01/04/2012EP2402329A1 Analgetic phenylsulphonamides
01/04/2012EP2402310A1 CCR9 inhibitors and methods of use thereof
01/04/2012EP2402309A1 CCR9 inhibitors and methods of use thereof
01/04/2012EP2402300A1 Hydroxyl compounds and compositions for cholesterol management and related uses
01/04/2012EP1339663B1 Naphthalene derivatives
01/04/2012CN102307889A Sulfurizing reagents and their use for oligonucleotides synthesis
01/04/2012CN101193858B Inhibitors of neurotrypsin and determination thereof
01/03/2012US8088762 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
01/03/2012CA2601508C Cyclopropanecarboxamide derivatives
01/03/2012CA2529464C Propionamide derivatives useful as androgen receptor modulators
01/03/2012CA2227265C Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/2011
12/29/2011WO2011161201A1 Bisarylsulfonamides useful as kinase inhibitors in the treatment of inflammation and cancer
12/29/2011US20110319438 Novel sulfonamides as l-cpt1 inhibitors
12/28/2011EP2399903A1 Ccr9 inhibitors and methods of use thereof
12/28/2011CN102300938A 新型三芳基甲烷化合物 The new triarylmethane compound
12/28/2011CN102298263A 滤色器用着色组合物、滤色器及其制造方法、蒽醌化合物以及液晶显示装置 The coloring composition for color filter, a color filter and manufacturing method thereof, an anthraquinone compound and a liquid crystal display device
12/27/2011US8084645 4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors
12/27/2011US8084615 Antibacterial agents
12/27/2011US8084607 Apoptosis promoters
12/27/2011US8084503 Indene derivatives as pharmaceutical agents
12/22/2011WO2011158321A1 Ionic compound, composition, cured product, hydrogel, and ocular lens
12/22/2011WO2011119345A3 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
12/22/2011US20110313000 Ccr9 inhibitors and methods of use thereof
12/22/2011US20110312964 Cysteine protease inhibitors
12/22/2011US20110312918 Method for identifying agents for inhibiting cell motility and invasiveness
12/21/2011EP2396308A1 New production method
12/21/2011EP2396296A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
12/15/2011US20110306614 N-Hydroxylsulfonamide Derivatives as New Physiologically Useful Nitroxyl Donors
12/14/2011EP1796193B1 Proton conductor and fuel cell using the same
12/14/2011CN102282128A 用于治疗癌症和免疫和自身免疫疾病的细胞程序死亡诱导药剂 Procedures for the treatment of cancer and cellular immune and autoimmune diseases inducing agent
12/14/2011CN102277387A 基因载体系统及其制备方法 Gene vector system and its preparation method
12/13/2011US8076513 Methods for the preparation of N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivatives
12/13/2011US8076376 Aniline sulfonamide derivatives and their uses
12/13/2011CA2494628C Acylated arylcycloalkylamines and their use as pharmaceuticals
12/07/2011EP2392923A1 Method of prodcucing proteins comprising unnatural amino acid
12/07/2011EP2392561A1 Alpha-acylaminoketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
12/07/2011CN102267929A 新型n-氨基酸取代薁磺酰胺药物的制备与抗胃溃疡作用 N- novel amino acid substitutions azulene sulfonamide drug preparation and gastric ulcer
12/07/2011CN102267924A 抗菌剂 Antibacterial agents
12/06/2011US8071650 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 177